Published in Infect Immun on January 01, 1991
Clonal relationships among Escherichia coli strains that cause hemorrhagic colitis and infantile diarrhea. Infect Immun (1993) 6.72
Enteropathogenic Escherichia coli. Infect Immun (1992) 5.74
Plasmid and chromosomal elements involved in the pathogenesis of attaching and effacing Escherichia coli. Infect Immun (1991) 3.13
Identification of enteropathogenic Escherichia coli by PCR-based detection of the bundle-forming pilus gene. J Clin Microbiol (1995) 2.60
Functional comparison of serine protease autotransporters of enterobacteriaceae. Infect Immun (2002) 2.44
Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev (2013) 2.43
Role of intimin and bundle-forming pili in enteropathogenic Escherichia coli adhesion to pediatric intestinal tissue in vitro. Infect Immun (1998) 2.41
Virulence of enteropathogenic Escherichia coli, a global pathogen. Clin Microbiol Rev (2003) 2.01
Etiology of diarrhea in young children in Denmark: a case-control study. J Clin Microbiol (2005) 1.89
Escherichia coli and community-acquired gastroenteritis, Melbourne, Australia. Emerg Infect Dis (2004) 1.74
Escherichia coli serogroup O111 includes several clones of diarrheagenic strains with different virulence properties. Infect Immun (1994) 1.74
Ability of enteroaggregative Escherichia coli strains to adhere in vitro to human intestinal mucosa. Infect Immun (1992) 1.73
Cytoskeletal effects induced by pet, the serine protease enterotoxin of enteroaggregative Escherichia coli. Infect Immun (1999) 1.65
Enteropathogenic escherichia coli infection in children. Curr Opin Infect Dis (2011) 1.63
Isolation and serologic characterization of AIDA-I, the adhesin mediating the diffuse adherence phenotype of the diarrhea-associated Escherichia coli strain 2787 (O126:H27). Infect Immun (1992) 1.60
Adhesion and its role in the virulence of enteropathogenic Escherichia coli. Clin Microbiol Rev (1994) 1.56
Clonal structure and virulence factors in strains of Escherichia coli of the classic serogroup O55. Infect Immun (1996) 1.51
Virulence properties and clonal structures of strains of Escherichia coli O119 serotypes. Infect Immun (1997) 1.48
Characteristics of Escherichia coli strains belonging to enteropathogenic E. coli serogroups isolated in Italy from children with diarrhea. J Clin Microbiol (1996) 1.40
A localized adherence-like pattern as a second pattern of adherence of classic enteropathogenic Escherichia coli to HEp-2 cells that is associated with infantile diarrhea. Infect Immun (1999) 1.35
SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system. Infect Immun (2005) 1.32
Chronic diarrhea, hemorrhagic colitis, and hemolytic-uremic syndrome associated with HEp-2 adherent Escherichia coli in adults infected with human immunodeficiency virus in Bangui, Central African Republic. J Clin Microbiol (2002) 1.29
Adherence characteristics of attaching and effacing strains of Escherichia coli from rabbits. Infect Immun (1994) 1.27
Characterization of enteropathogenic and enteroaggregative Escherichia coli isolated from diarrheal outbreaks. J Clin Microbiol (2002) 1.25
Virulence properties of Escherichia coli strains belonging to serogroups O26, O55, O111 and O128 isolated in the United Kingdom in 1991 from patients with diarrhoea. Epidemiol Infect (1993) 1.20
Comparative sequence analysis of the plasmid-encoded regulator of enteropathogenic Escherichia coli Strains. Infect Immun (2001) 1.16
HEp-2 cell adherence, actin aggregation, and intimin types of attaching and effacing Escherichia coli strains isolated from healthy infants in Germany and Australia. Infect Immun (2003) 1.10
Pathogenesis of Providencia alcalifaciens-induced diarrhea. Infect Immun (1992) 1.08
Bovine feces from animals with gastrointestinal infections are a source of serologically diverse atypical enteropathogenic Escherichia coli and Shiga toxin-producing E. coli strains that commonly possess intimin. Appl Environ Microbiol (2005) 1.03
Monoclonal antibodies specific for the bundle-forming pilus of enteropathogenic Escherichia coli. Infect Immun (1995) 0.99
Attaching-effacing lesions and intracellular penetration in HeLa cells and human duodenal mucosa by two Escherichia coli strains not belonging to the classical enteropathogenic E. coli serogroups. Infect Immun (1993) 0.96
Adherence factors in atypical enteropathogenic Escherichia coli strains expressing the localized adherence-like pattern in HEp-2 cells. J Clin Microbiol (2009) 0.95
Cytokeratin 8 is an epithelial cell receptor for Pet, a cytotoxic serine protease autotransporter of Enterobacteriaceae. MBio (2013) 0.86
Evaluation of the fluorescence actin staining test for detection of enteropathogenic Escherichia coli. J Clin Microbiol (1993) 0.82
Attaching and effacing enteropathogenic Escherichia coli O18ab invades epithelial cells and causes persistent diarrhea. Infect Immun (1996) 0.80
Use of an alkaline phosphatase-conjugated oligonucleotide probe for the gene encoding the bundle-forming pilus of enteropathogenic Escherichia coli. J Clin Microbiol (1996) 0.80
Contribution of a novel gene, rpeA, encoding a putative autotransporter adhesin to intestinal colonization by rabbit-specific enteropathogenic Escherichia coli. Infect Immun (2007) 0.80
Enteroaggregative coli: A Pathogen Bridging the North and South. Curr Trop Med Rep (2014) 0.78
Subdomain 2 of the Autotransporter Pet Is the Ligand Site for Recognizing the Pet Receptor on the Epithelial Cell Surface. Infect Immun (2016) 0.78
pH changes during in vitro adherence of Escherichia coli to HeLa cells. Infect Immun (1994) 0.77
Direct detection of eae-positive bacteria in human and veterinary colorectal specimens by PCR. J Clin Microbiol (1998) 0.77
Infantile diarrhoea associated with sorbitol-fermenting, non-shiga toxin-producing Escherichia coli O157:H-. Eur J Clin Microbiol Infect Dis (2003) 0.75
Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli. Infect Immun (1989) 12.91
Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect Immun (1983) 12.81
Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. J Infect Dis (1987) 12.26
The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J Infect Dis (1985) 9.18
A clinicopathologic study of enterocyte-adherent Escherichia coli: a cause of protracted diarrhea in infants. Gastroenterology (1982) 8.38
Pathogenesis of escherichia coli gastroenteritis in man--another mechanism. N Engl J Med (1980) 8.01
Detection of an adherence factor of enteropathogenic Escherichia coli with a DNA probe. J Infect Dis (1985) 7.78
Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells. Pediatr Infect Dis J (1987) 7.15
Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa. Infect Immun (1987) 6.77
Plasmid-mediated adhesion in enteropathogenic Escherichia coli. J Pediatr Gastroenterol Nutr (1983) 6.59
Plasmid-mediated factors conferring diffuse and localized adherence of enteropathogenic Escherichia coli. Infect Immun (1985) 5.42
Role of plasmid-encoded adherence factors in adhesion of enteropathogenic Escherichia coli to HEp-2 cells. Infect Immun (1987) 4.48
Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes. J Gen Microbiol (1987) 4.35
Traditional enteropathogenic Escherichia coli of infantile diarrhea. Rev Infect Dis (1987) 4.01
The pathogenesis of hemorrhagic colitis caused by Escherichia coli O157:H7 in gnotobiotic piglets. J Infect Dis (1986) 3.96
Nature and distribution of mucosal lesions associated with enteropathogenic and enterohemorrhagic Escherichia coli in piglets and the role of plasmid-mediated factors. Infect Immun (1989) 3.51
Use of DNA probes and HEp-2 cell adherence assay to detect diarrheagenic Escherichia coli. J Infect Dis (1988) 3.19
Prevalence of Escherichia coli strains with localized, diffuse, and aggregative adherence to HeLa cells in infants with diarrhea and matched controls. J Clin Microbiol (1989) 3.02
From the National Institute of Allergy and Infectious Diseases. Summary of a workshop on enteropathogenic Escherichia coli. J Infect Dis (1983) 2.71
Serotype-specific prevalence of Escherichia coli strains with EPEC adherence factor genes in infants with and without diarrhea in São Paulo, Brazil. J Infect Dis (1989) 2.35
HeLa cell-adherent Escherichia coli in children with diarrhea in Thailand. J Infect Dis (1987) 1.93
HEp-2 cell adherence as an assay for virulence among diarrheagenic Escherichia coli. J Infect Dis (1989) 1.60
"Enteropathogenic serotypes" of Escherichia coli which really are not. J Pediatr (1977) 1.22
Adhesion to cells in culture and plasmid profiles of enteropathogenic Escherichia coli isolated from outbreaks and sporadic cases of infant diarrhoea. J Infect (1989) 1.20
Virulence factors of enteropathogenic Escherichia coli. J Med Microbiol (1988) 1.07
Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol (1997) 37.26
Catching goldfish: quality in qualitative research. J Health Serv Res Policy (1998) 34.08
STUDIES OF THE HEART AND CIRCULATION IN DISEASE; ESTIMATIONS OF BASAL CARDIAC OUTPUT, METABOLISM, HEART SIZE, AND BLOOD PRESSURE IN 235 SUBJECTS. J Clin Invest (1934) 15.53
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology (1999) 11.94
Qualitative research methods in health technology assessment: a review of the literature. Health Technol Assess (1998) 9.45
Information needs and decisional preferences in women with breast cancer. JAMA (1997) 7.46
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ (1993) 7.14
Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet (1991) 6.61
Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol Microbiol (1998) 6.12
Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87
Clonal distribution of resistance plasmid-carrying Salmonella typhimurium, mainly in the Middle East. J Hyg (Lond) (1977) 4.46
Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes. J Gen Microbiol (1987) 4.35
Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science (2001) 4.18
Specific and nonspecific NK cell activation during virus infection. Nat Immunol (2001) 4.02
Haemorrhagic colitis and Vero-cytotoxin-producing Escherichia coli in England and Wales. Lancet (1987) 3.79
Chloramphenicol resistance in the typhoid bacillus. Br Med J (1972) 3.79
Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet (1999) 3.78
Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology (1993) 3.76
A study of infectious intestinal disease in England: microbiological findings in cases and controls. Commun Dis Public Health (1999) 3.72
Shifting dominance within a montane vegetation community: results of a climate-warming experiment. Science (1995) 3.61
Cloning of genes determining the production of vero cytotoxin by Escherichia coli. J Gen Microbiol (1985) 3.60
Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. Arch Dis Child (1990) 3.51
HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res (2001) 3.27
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst (1999) 3.26
Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol (1988) 3.25
Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res (1994) 3.25
VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation (2000) 3.13
Isolation of bacteriophages specific for the K1 polysaccharide antigen of Escherichia coli. J Clin Microbiol (1977) 3.11
Molecular studies of an fi+ plasmid from strains of Salmonella typhimurium. Mol Gen Genet (1973) 3.05
Application of agarose gel electrophoresis to the characterization of plasmid DNA in drug-resistant enterobacteria. J Gen Microbiol (1979) 3.02
Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2. Epidemiol Infect (1987) 2.98
Mutagenesis of plasmid DNA with hydroxylamine: isolation of mutants of multi-copy plasmids. Mol Gen Genet (1976) 2.92
Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer (2001) 2.82
Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet (1991) 2.80
Effect of temperature on invertase, invertase inhibitor, and sugars in potato tubers. Plant Physiol (1966) 2.54
beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci U S A (1998) 2.54
A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer (1997) 2.53
The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell (2001) 2.53
Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis (2012) 2.52
Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res Treat (1988) 2.51
Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet (1985) 2.47
Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol (1998) 2.47
Panoramic radiographs. Br Dent J (1996) 2.46
Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. Antiviral Res (2006) 2.43
Neonatal meningitis caused by Citrobacter koseri. J Clin Pathol (1973) 2.43
Comparison of physical treatments versus a brief pain-management programme for back pain in primary care: a randomised clinical trial in physiotherapy practice. Lancet (2005) 2.43
Role of intimin and bundle-forming pili in enteropathogenic Escherichia coli adhesion to pediatric intestinal tissue in vitro. Infect Immun (1998) 2.41
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res (1994) 2.39
Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (1996) 2.33
Increasing incidence of breast cancer in family with BRCA1 mutation. Lancet (1993) 2.33
Enterotoxin testing of Escherichia coli causing epidemic infantile enteritis in the U.K. Lancet (1976) 2.31
Two infant vision screening programmes: prediction and prevention of strabismus and amblyopia from photo- and videorefractive screening. Eye (Lond) (1996) 2.25
Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157. J Infect Dis (1992) 2.23
Surgically induced necrotising sclerokeratitis (SINS)--precipitating factors and response to treatment. Br J Ophthalmol (1992) 2.22
Genetic instability of microsatellites in endometrial carcinoma. Cancer Res (1993) 2.20
Genetic and molecular characterisation of some non-transferring plasmids. Mol Gen Genet (1974) 2.16
Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation (2001) 2.14
Cocaine-related vasculitis causing upper-limb peripheral vascular disease. Ann Intern Med (2000) 2.01
Syndrome of intractable diarrhoea with persistent villous atrophy in early childhood: a clinicopathological survey of 47 cases. J Pediatr Gastroenterol Nutr (1998) 1.97
Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J Allergy Clin Immunol (1992) 1.95
Facial dyskinesia: a 16-year follow-up study. Br J Psychiatry (1991) 1.94
DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. Arch Intern Med (1993) 1.91
Detective quantum efficiency of imaging systems with amplifying and scattering mechanisms. J Opt Soc Am A (1987) 1.88
Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome. Br J Psychiatry (1998) 1.86
Non-radioactively labelled polynucleotide and oligonucleotide DNA probes, for selectively detecting Escherichia coli strains producing Vero cytotoxins VT1, VT2 and VT2 variant. Mol Cell Probes (1991) 1.86
Interactions of group H resistance factors with the F factor. J Bacteriol (1973) 1.85
Properties of strains of Escherichia coli O26:H11 in relation to their enteropathogenic or enterohemorrhagic classification. J Infect Dis (1990) 1.84
Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation (1997) 1.83
cDNA cloning of mouse NKR-P1 and genetic linkage with LY-49. Identification of a natural killer cell gene complex on mouse chromosome 6. J Immunol (1991) 1.82
The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab (1997) 1.82
Induction of allergic inflammation in the lungs of sensitized sheep after local challenge with house dust mite. Clin Exp Allergy (2003) 1.82
The differential assessment of children's attention: the Test of Everyday Attention for Children (TEA-Ch), normative sample and ADHD performance. J Child Psychol Psychiatry (2001) 1.80
Roles for Fis and YafK in biofilm formation by enteroaggregative Escherichia coli. Mol Microbiol (2001) 1.80
Incidence of K1 antigen in Escherichia coli isolated from blood and cerebrospinal fluid of patients in the United Kingdom. J Clin Pathol (1977) 1.79
Vero cytotoxin-producing Escherichia coli, particularly serogroup O 157, associated with human infections in the United Kingdom: 1989-91. Epidemiol Infect (1993) 1.78
Adhesion of enteroaggregative Escherichia coli to pediatric intestinal mucosa in vitro. Infect Immun (1996) 1.78
Epidemic multiresistant Escherichia coli infection in West Lambeth Health District. Lancet (1988) 1.76
Intimin from enteropathogenic Escherichia coli restores murine virulence to a Citrobacter rodentium eaeA mutant: induction of an immunoglobulin A response to intimin and EspB. Infect Immun (1996) 1.76
Vero cytotoxin-producing Escherichia coli O157 outbreaks in England and Wales, 1995: phenotypic methods and genotypic subtyping. Emerg Infect Dis (1997) 1.75
Molecular characterization of a carboxy-terminal eukaryotic-cell-binding domain of intimin from enteropathogenic Escherichia coli. Infect Immun (1995) 1.75
Molecular comparison of plasmids encoding heat-labile enterotoxin isolated from Escherichia coli strains of human origin. J Bacteriol (1980) 1.75
Enterotoxigenicity of enteropathogenic serotypes of Escherichia coli isolated from infants with epidemic diarrhea. Infect Immun (1978) 1.74
Infantile gastroenteritis due to Escherichia coli 0142. Lancet (1972) 1.74
Identification of enteropathogenic Escherichia coli isolated in Britain as enteroaggregative or as members of a subclass of attaching-and-effacing E. coli not hybridising with the EPEC adherence-factor probe. J Med Microbiol (1991) 1.73
Ability of enteroaggregative Escherichia coli strains to adhere in vitro to human intestinal mucosa. Infect Immun (1992) 1.73
Vero cytotoxin production in strain of Escherichia coli is determined by genes carried on bacteriophage. Lancet (1983) 1.73
Mapping of a plasmid, coding for colonization, factor antigen I and heat-stable enterotoxin production, isolated from an enterotoxigenic strain of Escherichia coli. J Bacteriol (1982) 1.73
Outbreak of infantile gastro-enteritis caused by Escherichia coli O114. Arch Dis Child (1970) 1.71
Response to autoimmune enteropathy to cyclosporin A therapy. Gut (1991) 1.71
Fertility inhibition in strains of Salmonella typhimurium. Mol Gen Genet (1972) 1.69
Plasmids coding for colonization factor antigen I and heat-stable enterotoxin production isolated from enterotoxigenic Escherichia coli: comparison of their properties. Infect Immun (1981) 1.68
Genetic control and properties of coli surface antigens of colonization factor antigen IV (PCF8775) of enterotoxigenic Escherichia coli. Infect Immun (1988) 1.67
A breast-ovarian cancer susceptibility gene maps to chromosome 17q21. Am J Hum Genet (1993) 1.66
First recognized community outbreak of haemorrhagic colitis due to verotoxin-producing Escherichia coli O 157.H7 in the UK. Epidemiol Infect (1988) 1.66
Expression of CFA/I fimbriae is positively regulated. Microb Pathog (1990) 1.65